Clinical Trial

A Study of CRD3874-SI in People With Leukemia

Name: A Study of CRD3874-SI in People With Leukemia — clinical trial record (NCT07661095)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML).

Trial Details

NCT Number	NCT07661095
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Acute Myeloid Leukemia, AML, Refractory Acute Myeloid Leukemia
Enrollment	24 participants
Start Date	2026-06-15
Primary Completion	2028-06-15 (estimated)
Study Completion	2028-06-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-22